Literature DB >> 184301

Physical and metabolic requirements for early interaction of poliovirus and human rhinovirus with HeLa cells.

K Lonberg-Holm, N M Whiteley.   

Abstract

Attachment, ""tight binding'' and eclipse of radioactive poliovirus 2 (P2) and human rhinovirus 2 (HRV 2) were investigated. The activation energy for attachment of both HRV2 and P2 was about 13 kcal/mol. HRV2 differed from P2 in two respects: the Arrhenius plot for attachment of HRV2 showed a break at 15 to 19 degrees C when the cells were first treated several hours at 0 degrees C, and attachment of HRV2 was inhibited by treatment of cells with metabolic poisons able to reduce cellular ATP by more than 90%. Tight binding was determined by isolation of a specific P2-membrane complex or by loss of EDTA dissociability of HRV2. Tight binding of both viruses was slowed by 0.01 M iodoacetamide but not by 0.02 M F-; F- plus 0.002 M CN- slowed tight binding of HRV2 but not of P2. Eclipse, the irreversible alteration of parental virions, was detected by isolation of cell-associated subviral particles or by loss of cell-associated infectious virus. Eclipse of both viruses is slowed by iodoacetamide or F-. It seems likely that the early steps of infection with picornaviruses may be sensitive to alterations in the cell membrane produced by metabolic inhibitors or by treatment at low temperature.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184301      PMCID: PMC354926     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Effects of temperature and host lipid composition on the infection of cells by Newcastle disease virus.

Authors:  J K Li; R E Williams; C F Fox
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

2.  On uncertainties inherent in the determination of the efficiency of collision between virus particles and cells.

Authors:  A G OGSTON
Journal:  Biochim Biophys Acta       Date:  1963-03-19

3.  Further studies on the infection of pig-kidney cells by foot-and-mouth disease virus.

Authors:  F BROWN; B CARTWRIGHT; D L STEWART
Journal:  Biochim Biophys Acta       Date:  1962-05-14

4.  Irreversible eclipse of poliovirus by HeLa cells.

Authors:  J J HOLLAND
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

5.  Virus particle adsorption. I. Theory of adsorption and experiments on the attachment of particles to non-biological surfaces.

Authors:  R C VALENTINE; A C ALLISON
Journal:  Biochim Biophys Acta       Date:  1959-07

6.  The basis for variation in susceptibility to poliovirus in HeLa cells.

Authors:  J E DARNELL; T K SAWYER
Journal:  Virology       Date:  1960-08       Impact factor: 3.616

7.  The adsorption and early fate of purified poliovirus in HeLa cells.

Authors:  W K JOKLIK; J E DARNELL
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

8.  Elution and uncoating of Coxsackievirus B3 by isolated HeLa cell plasma membranes.

Authors:  T G Roesing; P A Toselli; R L Crowell
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

9.  The mammalian cell-virus relationship. I. Attachment of poliovirus to cultivated cells of primate and non-primate origin.

Authors:  L C McLAREN; J J HOLLAND; J T SYVERTON
Journal:  J Exp Med       Date:  1959-05-01       Impact factor: 14.307

10.  The mammalian cell-virus relationship. II. Adsorption, reception, and eclipse of poliovirus by HeLa cells.

Authors:  J J HOLLAND; L C McLAREN
Journal:  J Exp Med       Date:  1959-05-01       Impact factor: 14.307

View more
  23 in total

1.  Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis.

Authors:  Marianne Brabec; Daniela Schober; Ernst Wagner; Nora Bayer; Robert F Murphy; Dieter Blaas; Renate Fuchs
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Multiple receptors involved in human rhinovirus attachment to live cells.

Authors:  Christian Rankl; Ferry Kienberger; Linda Wildling; Jürgen Wruss; Hermann J Gruber; Dieter Blaas; Peter Hinterdorfer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

3.  Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells.

Authors:  T Wilson; D Papahadjopoulos; R Taber
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

4.  Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment.

Authors:  M Gromeier; K Wetz
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Authors:  R M Powell; T Ward; D J Evans; J W Almond
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.

Authors:  D Schober; P Kronenberger; E Prchla; D Blaas; R Fuchs
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Cold-adapted poliovirus mutants bypass a postentry replication block.

Authors:  A W Dove; V R Racaniello
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells.

Authors:  C M Wheeler; H A Fields; C A Schable; W J Meinke; J E Maynard
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

9.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

10.  Specific binding sites for a parvovirus, minute virus of mice, on cultured mouse cells.

Authors:  P Linser; H Bruning; R W Armentrout
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.